|
MicroRNAs (miRNAs) for the Treatment of Neurological Disorders
Application
Oligonucleotides that target Kv4.2 miRNAs for the upregulation of Kv4.2 protein in neurological disorders.
Key Benefits
Increases the abundance of the neuro-protective protein, Kv4.2.
Offers a potential treatment for neurological diseases, including Fragile X syndrome, autism spectrum disorders, epilepsy, and Alzheimer's disease.
Market...
Published: 3/19/2024
Contributor(s): Gary Bassell, Xiaodi Yao, Christina Gross
|